Journal
DEVELOPMENTAL CELL
Volume 49, Issue 3, Pages 393-+Publisher
CELL PRESS
DOI: 10.1016/j.devcel.2019.03.011
Keywords
-
Categories
Funding
- NIH [R35 GM122575, R01 CA101402, U54 CA210184, DK107868, F99 CA234921]
- Breast Cancer Coalition of Rochester
- NSF [1428922, NNCI-1542081]
Ask authors/readers for more resources
The NAD(+)-dependent deacetylase Sirtuin 1 (SIRT1) is down-regulated in triple-negative breast cancer. To determine the mechanistic basis by which reduced SIRT1 expression influences processes related to certain aggressive cancers, we examined the consequences of depleting breast cancer cells of SIRT1. We discovered that reducing SIRT1 levels decreased the expression of one particular subunit of the vacuolar-type H+ ATPase (V-ATPase), which is responsible for proper lysosomal acidification and protein degradation. This impairment in lysosomal function caused a reduction in the number of multi-vesicular bodies (MVBs) targeted for lysosomal degradation and resulted in larger MVBs prior to their fusing with the plasma membrane to release their contents. Collectively, these findings help explain how reduced SIRT1 expression, by disrupting lysosomal function and generating a secretome comprising exosomes with unique cargo and soluble hydrolases that degrade the extracellular matrix, can promote processes that increase breast-cancer-cell survival and invasion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available